Firstly, we assessed any deregulated differences of the PLAGL2 mRNA level in glioma compared to normal brain tissues, which were tested using the data in human glioma from publicly available microarray datasets (https://www.oncomine.org/) (Rhodes et al., 2004). This evidence concerns the gene PLAGL2 and central nervous system cancer.